APA (7th ed.) Citation

Q, L., Y, X., J, G., L, T., & Y, Z. (2025). Citrate: A key signalling molecule and therapeutic target for bone remodeling disorder. Frontiers in endocrinology, 15, 1512398. https://doi.org/10.3389/fendo.2024.1512398

Chicago Style (17th ed.) Citation

Q, Liu, Xue Y, Guo J, Tao L, and Zhu Y. "Citrate: A Key Signalling Molecule and Therapeutic Target for Bone Remodeling Disorder." Frontiers in Endocrinology 15 (2025): 1512398. https://doi.org/10.3389/fendo.2024.1512398.

MLA (9th ed.) Citation

Q, Liu, et al. "Citrate: A Key Signalling Molecule and Therapeutic Target for Bone Remodeling Disorder." Frontiers in Endocrinology, vol. 15, 2025, p. 1512398, https://doi.org/10.3389/fendo.2024.1512398.